Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

  • There is currently no data for INDV

Block listing Interim Review

9 Nov 2020 08:48

RNS Number : 6531E
Indivior PLC
09 November 2020
 

BLOCK LISTING SIX MONTHLY RETURN

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

LONG-TERM INCENTIVE PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

6,360,554 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

19,702

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

6,340,852 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

UK SAVINGS RELATED SHARE OPTION PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

1,000,000 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

1,000,000 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423 940

 

 

Date: November 9, 2020

 

Name of applicant:

INDIVIOR PLC

Name of scheme:

U.S. EMPLOYEE STOCK PURCHASE PLAN

Period of return:

From:

MAY 10, 2020

To:

NOVEMBER 9, 2020

Balance of unallotted securities under scheme(s) from previous return:

780,891 ORDINARY SHARES OF US$0.10

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

5,000,000

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

1,048,667

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

4,732,224 ORDINARY SHARES OF US$0.10

 

Name of contact:

KATHRYN HUDSON

Telephone number of contact:

01753 423940

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRBLBPTMTIMMAM
Date   Source Headline
3rd May 20227:00 amRNSShare Repurchase Program
28th Apr 20227:00 amRNS1st Quarter Results
27th Apr 20227:00 amRNSAppointment of Independent Non-Executive Director
25th Apr 20225:18 pmRNSCommittee Change
7th Apr 202210:30 amRNSNotice of Q1 Results
1st Apr 202210:05 amRNSTotal Voting Rights
31st Mar 20222:00 pmRNSIndivior to Commence Consultations
30th Mar 20223:16 pmRNSAnnual Report and Accounts and Notice of AGM
16th Mar 20221:04 pmRNSDirector/PDMR Shareholding
15th Mar 20221:00 pmRNSDirector/PDMR Shareholding
15th Mar 20221:00 pmRNSDirector/PDMR Shareholding
8th Mar 20221:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202212:22 pmRNSDirector/PDMR Shareholding
18th Feb 202212:10 pmRNSDirector/PDMR Shareholding
16th Feb 20227:00 amRNSFinal Results
1st Feb 202211:41 amRNSTotal Voting Rights
1st Feb 20229:23 amRNSNotice of Results
28th Jan 20227:00 amRNSBuprenorphine-Fentanyl Interaction Study Results
4th Jan 202210:53 amRNSTotal Voting Rights
29th Dec 20211:00 pmRNSTransaction in Own Shares
24th Dec 20217:00 amRNSTransaction in Own Shares
23rd Dec 20217:00 amRNSTransaction in Own Shares
22nd Dec 20217:00 amRNSTransaction in Own Shares
21st Dec 20217:00 amRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
17th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 20217:00 amRNSTransaction in Own Shares
15th Dec 20213:13 pmRNSBlock Listing Application
15th Dec 20217:00 amRNSTransaction in Own Shares
14th Dec 20217:00 amRNSTransaction in Own Shares
13th Dec 20217:00 amRNSTransaction in Own Shares
10th Dec 20217:00 amRNSTransaction in Own Shares
9th Dec 20217:00 amRNSTransaction in Own Shares
8th Dec 20217:00 amRNSTransaction in Own Shares
7th Dec 20217:00 amRNSTransaction in Own Shares
6th Dec 20217:00 amRNSTransaction in Own Shares
3rd Dec 20217:00 amRNSTransaction in Own Shares
2nd Dec 20217:00 amRNSTransaction in Own Shares
1st Dec 202111:52 amRNSTotal Voting Rights
1st Dec 20217:00 amRNSTransaction in Own Shares
30th Nov 20214:05 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTransaction in Own Shares
29th Nov 20217:00 amRNSTransaction in Own Shares
26th Nov 20217:00 amRNSTransaction in Own Shares
25th Nov 20217:00 amRNSTransaction in Own Shares
24th Nov 20217:00 amRNSTransaction in Own Shares
23rd Nov 20217:00 amRNSTransaction in Own Shares
22nd Nov 20217:00 amRNSTransaction in Own Shares
19th Nov 20217:00 amRNSTransaction in Own Shares
18th Nov 20214:00 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.